<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02880384</url>
  </required_header>
  <id_info>
    <org_study_id>16-172A</org_study_id>
    <nct_id>NCT02880384</nct_id>
  </id_info>
  <brief_title>Pathogen Detection and Community Acquired Pneumonia</brief_title>
  <official_title>Projected Influence of Enhanced Pathogen Detection on the Clinical Management of Community-Acquired Pneumonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Providence Health &amp; Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BioFire Diagnostics, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Providence Health &amp; Services</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using
      current diagnostic tests to the number detected using the BioFire Diagnostics investigational
      polymerase chain reaction (PCR) platform.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients diagnosed in the emergency department with CAP that requires hospitalization provide
      a sputum sample for culture and sensitivity testing, urine for detection of S. pneumonia and
      L. pneumophila, an anterior nasal swab for S. aureus PCR, a nasopharyngeal swab for S.
      pneumonia PCR and the FilmArray LRTI v.2.0 IUO Panel, and blood for procalcitonin testing
      and, in cases in which the patient is suffering rigors and hypotension, cultures. As part of
      this study, sputum or sputum equivalent will be acquired for testing using the FilmArray LRTI
      v.2.0 IUO Panel.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pathogen Detection</measure>
    <time_frame>5 Days</time_frame>
    <description>Compare the number of CAP pathogens detected using current diagnostic bundle to the number detected using the FilmArray LRTI v.2.0 IUO Panel.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Influence</measure>
    <time_frame>5 Days</time_frame>
    <description>Determine the number of cases in which the FilmArray LRTI v.2.0 IUO Panel could allow for a switch from empiric to specific antimicrobial therapy if the results had been known by the healthcare provider.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nasopharyngeal swabs compared to sputum</measure>
    <time_frame>5 Days</time_frame>
    <description>Compare the number of pathogens detected using an approved PCR panel using nasopharyngeal swabs to the number detected using the FilmArray LRTI v.2.0 IUO Panel.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">570</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>FilmArray LRTI v.2.0 IUO Panel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will provide sputum or sputum equivalent for FilmArray LRTI v.2.0 IUO Panel testing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>FilmArray LRTI v.2.0 IUO Panel</intervention_name>
    <description>Patients will provide sputum or sputum equivalent to be probed with FilmArray LRTI v.2.0 IUO Panelpanel.</description>
    <arm_group_label>FilmArray LRTI v.2.0 IUO Panel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Emergency Department physician diagnosis of CAP requiring hospitalization

        Exclusion Criteria:

          -  Inability to obtain sputum or sputum equivalent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Gilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Providence Health &amp; Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Portland Providence Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>August 23, 2016</study_first_submitted>
  <study_first_submitted_qc>August 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2016</study_first_posted>
  <last_update_submitted>June 5, 2018</last_update_submitted>
  <last_update_submitted_qc>June 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

